Compare
Kyndryl Holdings, Inc. vs Leidos Holdings, Inc. vs Science Applications International Corp vs Parsons Corp
| Latest fiscal year | Kyndryl Holdings, Inc. KD | Leidos Holdings, Inc. LDOS | Science Applications International Corp SAIC | Parsons Corp PSN |
|---|---|---|---|---|
| Year ended | 2026-03-31 | 2026-01-02 | 2026-01-30 | 2025-12-31 |
| Revenue | $15.09B | $17.17B | $7.26B | $6.36B |
| Revenue growth (YoY) | +0.2% | +3.1% | -2.9% | -5.7% |
| Gross margin | 21.8% (computed) | 18.0% (computed) | 12.0% (computed) | 22.5% (computed) |
| Operating margin | n/a | 12.3% | 7.2% | 6.6% |
| Net margin | 1.3% | 8.4% | 4.9% | 3.8% |
| Net income | $198.00M | $1.45B | $358.00M | $241.14M |
| EPS (Diluted) | $0.85 | $11.14 | $7.70 | $2.20 |
| Operating cash flow | $948.00M | $1.75B | $609.00M | $478.38M |
| Free cash flow | $340.00M | $1.62B | $577.00M | $410.41M |
| Cash & equivalents | $2.62B | $1.11B | $182.00M | $466.39M |
| Total assets | $12.55B | $13.49B | $5.35B | $5.77B |
| Total liabilities | $11.26B | $8.53B | n/a | $3.00B |
| Shareholders' equity | $1.29B | $4.92B | $1.50B | $2.77B |
| Return on year-end equity | 15.3% | 29.5% | 23.9% | 8.7% |
| Shares outstanding | n/a | 126.38M | 44.00M | 56.10M |
Revenue, most recent five fiscal years
| Fiscal year | Kyndryl Holdings, Inc. | Leidos Holdings, Inc. | Science Applications International Corp | Parsons Corp |
|---|---|---|---|---|
| Latest | $15.09B Ended 2026-03-31 | $17.17B Ended 2026-01-02 | $7.26B Ended 2026-01-30 | $6.36B Ended 2025-12-31 |
| 1 year earlier | $15.06B Ended 2025-03-31 | $16.66B Ended 2025-01-03 | $7.48B Ended 2025-01-31 | $6.75B Ended 2024-12-31 |
| 2 years earlier | $16.05B Ended 2024-03-31 | $15.44B Ended 2023-12-29 | $7.44B Ended 2024-02-02 | $5.44B Ended 2023-12-31 |
| 3 years earlier | $17.03B Ended 2023-03-31 | $14.40B Ended 2022-12-30 | $7.70B Ended 2023-02-03 | $4.20B Ended 2022-12-31 |
| 4 years earlier | n/a | $13.74B Ended 2021-12-31 | $7.39B Ended 2022-01-28 | $3.66B Ended 2021-12-31 |